Company Profile

Advanced Cell Diagnostics Inc (AKA: ACD)
Profile last edited on: 6/17/21      CAGE: 4FBA8      UEI: UD6XW8DAGLK6

Business Identifier: Molecular pathology: cell- and tissue-based diagnostics for personalized medicine
Year Founded
First Award
Latest Award
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

7707 Gateway Boulevard
Newark, CA 94560
   (510) 576-8800
Location: Single
Congr. District: 17
County: Alameda

Public Profile

In August 2016 it was announced that Advanced Cell Diagnostics, Inc. would be acquired by Bio-Techne Corporation (NASDAQ: TECH) in a primarily cash transaction with additional milestone payments. The firm now operates as a subsiduart of Bio-Techne. Advanced Cell Diagnostics (ACD) develops cell-and tissue-based diagnostic tests for personalized medicine: products and pharma assay services based on its proprietary RNAscope® technology, the first multiplex fluorescent and chromogenic in situ hybridization platform, capable of detecting and quantifying single molecules of RNA in situ. The company develops a portfolio of novel cancer diagnostic tests for the management of various ontological diseases, including head and neck cancer, cervical cancer, B-cell lymphoma, melanoma, breast cancer, and circulating tumor cells. It offers RNAscope formalin-fixed and paraffin-embedded (FFPE) assay kit that is designed to detect RNA biomarkers in routine FFPE tissue specimens with single molecule sensitivity and at single cell resolution. The company also provides clinical-grade assay development and biomarker analysis services to speed up biomarker validation; and companion diagnostic development, custom assay development, biomarker analysis, and clinical trial support services. It partners with pharmaceutical and biotechnology companies to validate biomarkers for targeted therapeutic development in cancer and other diseases. Advanced Cell Diagnostics, Inc. was founded in 2007 and is based in Hayward, California

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Key People / Management

  Yuling Luo -- Founder, President & CEO

  Christopher Bunker -- Senior Director, Business Development

  Steve Chen -- Founder, Chief Operating Officer

  Xiao-Jun Ma -- Chief Scientific Officer

  Tom Olenic -- Chief Commercial Officer